Can a late dose of tenecteplase still save stroke patients?
NCT ID NCT07536165
First seen Apr 20, 2026 · Last updated Apr 30, 2026 · Updated 4 times
Summary
This study looks at whether giving the clot-busting drug tenecteplase more than 4.5 hours after a stroke starts is safe and helpful. Researchers will follow 3,000 adults in China who receive this late treatment in regular hospital care. The goal is to see if patients have less disability three months later.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Liuyang Jili Hospital
Guankou, Hunan, China
-
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Guangzhou, Guangdong, China
Conditions
Explore the condition pages connected to this study.